Frontier Peptide Labs BPC-157 + TB-500 is intended exclusively for laboratory research and development purposes
GHK-Cu Titration Protocols: A Biomarker-Informed Framework Titration strategies for GHK-Cu are individualized, typically starting at lower doses and increasing over 412 weeks based on clinical response, injection site tolerance, and biomarker trends
Son S, Kim JH, Wang X, Zhang C, Yoon SA, Shin J, et al
They're sold in a legal gray zone as: "Research chemicals" "For laboratory use only" "Not for human consumption" Yet thousands of people are injecting them
It can be applied topically, it can be inhaled, and it can be administered through an IV in severe cases
Besides the interleukin family, other genes related to the skin inflammatory mechanism were also upregulated